Masteron 100 BodyPharm

£65.00

Description

Product Description: Masteron 100 BodyPharm

Masteron 100 BodyPharm is a high-quality anabolic steroid that is specifically designed to enhance the performance and physique of bodybuilders. With its potent formula and unique characteristics, this product offers numerous benefits for those looking to achieve their fitness goals.

Specific Details and Characteristics:

  • Active Ingredient: Drostanolone Propionate
  • Strength: 100mg/ml
  • Form: Injectable solution
  • Manufacturer: BodyPharm
  • Half-life: Approximately 2-3 days
  • Androgenic Rating: 25-40
  • Anabolic Rating: 62-130

Benefits:

  • Promotes lean muscle mass: Masteron 100 BodyPharm helps bodybuilders achieve a more defined and ripped physique by promoting the growth of lean muscle mass.
  • Enhances strength and endurance: This steroid improves strength and endurance levels, allowing users to push their limits during intense workouts.
  • Increases vascularity: By reducing water retention and promoting a dry appearance, Masteron 100 BodyPharm enhances vascularity, giving muscles a more pronounced and aesthetic look.
  • Boosts fat burning: This product aids in the breakdown of stored body fat, making it an excellent choice for cutting cycles.
  • Improves overall athletic performance: Masteron 100 BodyPharm enhances speed, agility, and power, making it ideal for athletes looking to improve their performance.

Possible Side Effects:

While Masteron 100 BodyPharm is generally well-tolerated, it is essential to be aware of potential side effects, including:

  • Androgenic effects: Increased facial and body hair growth, acne, and potential hair loss in individuals predisposed to male pattern baldness.
  • Cardiovascular risks: Masteron 100 BodyPharm may negatively impact cholesterol levels, so regular monitoring is recommended.
  • Virilization in women: Female users may experience masculinizing effects, such as deepening of the voice and enlargement of the clitoris.

Usage, Administration, and Dosage:

Masteron 100 BodyPharm is typically administered through intramuscular injections. The recommended dosage for bodybuilders is 200-400mg per week, divided into two equal doses. The duration of the cycle usually ranges from 6 to 12 weeks.

Indications and Contraindications:

Masteron 100 BodyPharm is indicated for individuals who are looking to enhance their physique, improve athletic performance, and achieve a more defined and muscular appearance. However, it is important to note that this product is not suitable for everyone. It should not be used by individuals with the following conditions:

  • Prostate or breast cancer
  • High blood pressure
  • Liver or kidney problems
  • Heart disease
  • Allergies to any of the product’s components

Value and Why Buy from ukanabolic.com:

When purchasing Masteron 100 BodyPharm from ukanabolic.com, you can expect the following benefits:

  • Authenticity: We guarantee that all our products are genuine and sourced directly from reputable manufacturers.
  • Quality assurance: Our products undergo strict quality control measures to ensure their safety and effectiveness.
  • Discreet packaging: We prioritize your privacy and ensure that your order is discreetly packaged and delivered.
  • Competitive pricing: We offer competitive prices to provide you with the best value for your money.
  • Secure payment options: Our website provides secure payment options, ensuring your financial information is protected.
  • Fast and reliable shipping: We strive to deliver your order promptly and reliably, ensuring a smooth purchasing experience.

Choose Masteron 100 BodyPharm from ukanabolic.com and take your bodybuilding journey to the next level with confidence and peace of mind.

Additional information

Active ingredient

Drostanolone dipropionate

Active ingredient, mg

100

form of production

vial

1 bottle, ml

10

Bottles per pack, pcs.

1

Manufacturer

BodyPharm

Reviews

There are no reviews yet.

Be the first to review “Masteron 100 BodyPharm”

Your email address will not be published. Required fields are marked *